Financial Data and Key Metrics Changes - Health plan membership reached 236,300, reflecting a year-over-year growth of approximately 25% [4] - Total revenue for Q4 2025 was $1 billion, representing a 44% year-over-year increase, while full-year revenue was $3.9 billion, up 46% year-over-year [4][15] - Adjusted gross profit for Q4 was $125 million, with an adjusted medical benefit ratio (MBR) of 87.7%, and full-year adjusted gross profit was $495 million, with an MBR of 87.5%, improving by 130 basis points year-over-year [4][5][16] - Adjusted EBITDA for Q4 was $11 million, exceeding guidance, while full-year adjusted EBITDA was $110 million, marking a margin expansion of 270 basis points year-over-year [4][5][18] Business Line Data and Key Metrics Changes - The company demonstrated strong performance across all major cost categories, with inpatient admissions per thousand in the low 140s during Q4 [16] - The clinical model's effectiveness was highlighted, with a focus on delivering high-quality care at lower costs, contributing to the overall financial performance [6][13] Market Data and Key Metrics Changes - Membership outside California grew significantly, with approximately 38,000 members representing 16% of total membership by December 2025 [7] - The company achieved a 5-star plan in North Carolina and two 5-star plans in Nevada, indicating strong market performance [8] Company Strategy and Development Direction - The company aims to serve more seniors, targeting 1 million members, and plans to invest in sales and distribution to strengthen relationships with brokers and providers [9] - The focus for 2026 includes responsible growth, maintaining profitability, and leveraging the clinical model to navigate regulatory changes [10][11] - The company is committed to continuous improvement and targeted investments in clinical models and technology, including AI workflows [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a 20% growth rate despite potential challenges in the rate environment for 2027 [27] - The company anticipates a relatively flat rate environment for the industry, which may provide a level playing field for competition [12][13] - Management emphasized the importance of maintaining high-quality care and operational efficiency to succeed in any reimbursement environment [13][64] Other Important Information - The company generated positive free cash flow in 2025 and ended the year with $604 million in cash and investments [18] - A $200 million revolving credit facility was closed, indicating a strong capital structure [18] Q&A Session Summary Question: What would prevent Alignment from achieving similar growth in 2027 as in 2024 or 2025? - Management feels comfortable with a 20% growth rate and believes the model will work irrespective of rate changes [27] Question: Can you elaborate on the assumptions embedded in MLR for 2026? - Management indicated that the MLR improvement is about 10 basis points year-over-year, influenced by the new member mix and ongoing regulatory changes [31][37] Question: How is the company planning to change its distribution network? - The company is focusing on deeper relationships with brokers and providers, with plans to enter new markets without being overly reliant on rate changes [41][44] Question: What is the company's exposure to the risk model rebasing component? - Management believes the company is less exposed compared to others due to its blended RAF scores and focus on cost management [99] Question: How does the company view the potential changes from CMS regarding the Stars measures? - Management considers the potential changes to be net neutral and believes simplification of the Stars program could be beneficial [88]

Summary of Conference Call for Oscar Health Company Overview - **Company**: Oscar Health - **Industry**: Health Insurance Key Points and Arguments Third-Quarter Results - The third-quarter results were impacted by weekly data fluctuations, with expectations for stability moving forward [1][2] - Full-year guidance assumes no further decay in market morbidity for 2025, based on recent data [2] Market Morbidity and Risk Scores - Members who lost subsidies and left Oscar had higher risk scores, but this group represents less than 2% of the total membership [3] - Increased utilization pressure was noted in the industry, but Oscar's utilization has stabilized and is trending down [4][5] Utilization Management - Oscar has implemented measures to ensure members receive care at appropriate sites, contributing to improved utilization metrics [5][7] - The company has seen a positive shift in care categories due to proactive engagement with providers and members [7] Pricing Strategy - Oscar's premium increase of 28% year-over-year is competitive, with the company positioned as the lowest cost in 30% of its markets [8][9] - The pricing strategy involved extensive modeling, considering market morbidity, potential market contraction, and program integrity measures [10][11] Market Dynamics and Enrollment - The company anticipates a 20-30% contraction in the marketplace due to the expiration of enhanced subsidies, affecting affordability for many members [12][24] - Oscar has expanded into approximately 70 new counties, leveraging existing network relationships to enhance visibility and performance [13][14] Open Enrollment Performance - Early indicators of open enrollment are positive, with strong engagement from brokers and creative plan designs aimed at affordability [15][16] - Retention rates are expected to be lower than previous years due to subsidy losses, but initial retention stats are promising [16][25] Enhanced Subsidies and Future Outlook - Oscar has planned for 2026 without enhanced subsidies, indicating readiness for market changes [21] - The company remains optimistic about potential bipartisan solutions to support families in affording healthcare [19][20] Capital Management - Oscar has over $1 billion in excess capital, positioning the company well for growth and potential market changes [34][36] - The recent convertible debt reduction was a strategic move to improve liquidity and financial performance [31][33] Risks and Opportunities - The primary risk for 2026 is accurately pricing market morbidity, as mispricing could impact profitability [40][41] - Despite risks, Oscar is excited about opportunities for market share growth and profitability improvements in 2026 [41][42] Additional Important Insights - The company is focusing on Individual Coverage Health Reimbursement Arrangements (ICRAs) as a growth opportunity, despite skepticism in the market [38][39] - Oscar emphasizes the importance of maintaining access to affordable healthcare for essential workers and the gig economy [27][28]